Local News: Big Lake, AK 

 | 

Sign Up

 | 

Sign In

Advertisment

Zanaflex, Tizanidine

Zanaflex, Tizanidine News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Zanaflex, Tizanidine News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Zanaflex, Tizanidine News

News on Zanaflex, Tizanidine (generic) continually updated from thousands of sources around the net.

Tuesday Nov 24 | Freshnews

Acorda Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference

Acorda Therapeutics, Inc. today announced that Ron Cohen, M.D., President & CEO, will present at the upcoming 21st Annual Piper Jaffray Health Care Conference on Wednesday, December 2, 2009 at 9:30 a.m. ET at the New York Palace in New York, NY.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Acorda Therapeutics, New York Metro, Multiple Sclerosis, Health, Medication

Tue Nov 03, 2009

Medical News

Acorda Therapeutics' financial results for the third quarter of 2009 and update on Fampridine-SR

Acorda Therapeutics, Inc. today announced its financial results for the third quarter of 2009.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Acorda Therapeutics, Multiple Sclerosis, Health, Medication

Fri Oct 09, 2009

BioSpace

Us Fda Staff Says Limited Effect with Acorda Therapeutics MS Drug

Acorda Therapeutics, Inc. today announced that the U.S. Food and Drug Administration has posted on its website briefing documents for the Peripheral and Central Nervous System Drugs Advisory Committee meeting to review Acordaa s New Drug Application for Fampridine-SR for the proposed indication of improvement of walking ability in people with ...

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Acorda Therapeutics, Food and Drug Administration, Multiple Sclerosis, Health, Medication

Tue Aug 11, 2009

The Journal News

Post a Comment

Acorda Therapeutics Inc., a Hawthorne-based biotech company, reported a bigger quarterly loss as it awaited regulatory action on a new multiple sclerosis drug that is designed to make walking easier for the disease's victims.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Multiple Sclerosis, Health, Marketing, Medication, Regeneron Pharmaceuticals, Gout

The Journal News

Post a Comment

Acorda Therapeutics Inc., a Hawthorne-based biotech company, reported a bigger quarterly loss as it awaited regulatory action on a new multiple sclerosis drug that is designed to make walking easier for the disease's victims.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Multiple Sclerosis, Health, Marketing, Medication, Regeneron Pharmaceuticals, Gout

Wed Aug 05, 2009

Med Ad News

Acorda Therapeutics Names Ruhi Kahn as Vice President, Business Development

Previously, Ms. Khan was the Executive Director, Business Development at Acorda.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Science / Technology, Multiple Sclerosis, Health, Medication

The Journal News

Post a Comment

Acorda Therapeutics Inc., a Hawthorne-based biotech company, reported a bigger quarterly loss as it awaited regulatory action on a new multiple sclerosis drug that is designed to make walking easier for the disease's victims.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Multiple Sclerosis, Health, Marketing, Medication, Regeneron Pharmaceuticals, Gout

Wed Jul 29, 2009

Customer Interaction Solutions

www.PicksThatMove.com: 'Picks that move' Alerts, July 28, 2009: ACOR, ...

July 27, 2009 Acorda Therapeutics, Inc. closed at $26.35 on a volume of 323,472 shares.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Acorda Therapeutics, Hawthorne, NY, Multiple Sclerosis, Health, Medication, Semiconductors, Virage Logic, Electronics

Tue Jul 28, 2009

Med Ad News

Acorda Therapeutics to Host Conference Call to Report Second Quarter...

Jul 28, 2009 - Acorda Therapeutics, Inc. announced today that it will report its financial results for the second quarter 2009 on Tuesday, August 4, 2009 at 8:30 a.m. ET before the U.S. financial markets open.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Acorda Therapeutics, Multiple Sclerosis, Health, Medication

Mon Jun 08, 2009

Med Ad News

Acorda Therapeutics Announces Eligibility of Fampridine-SR for Centralized Review in Europe

Jun 8, 2009 - Acorda Therapeutics, Inc. today announced that, in response to its eligibility application to the European Medicines Agency for Fampridine-SR, the EMEA has notified the Company that Fampridine-SR is eligible to be submitted for a Marketing Authorization Application via the Agency's Centralized Procedure.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Acorda Therapeutics, Marketing, Food and Drug Administration, Medication

Thu Jun 04, 2009

WUSA9

Help For Those Who Suffer From Spasticity

Spasticity is a condition when certain muscles are continuously contracted. This contraction causes stiffness or tightness of the muscles and may interfere with movement, speech, and the way people walk.

Comment?

Related Topix: Medicine, Multiple Sclerosis, Health, Lioresal, Baclofen (generic), Medication

Sun May 10, 2009

Drugs.com

Acorda Therapeutics Announces FDA Acceptance of Fampridine-SR New Drug Application for Filing

May 6, 2009 - Acorda Therapeutics, Inc. today announced that the U.S. Food and Drug Administration has accepted the Fampridine-SR New Drug Application for filing, assigning Priority Review and a Prescription Drug User Fee Act date of October 22, 2009.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Acorda Therapeutics, Food and Drug Administration, Multiple Sclerosis, Health, Medication, Elan Corporation Plc

Wed Apr 29, 2009

MarketWatch

Study Highlights Economic Impact of Early Mobility Impairment in People with Multiple Sclerosis

HAWTHORNE, N.Y., Apr 29, 2009 -- --Greatest Changes in Income Level Due to Mobility Loss Occur Early On, as People with MS Transition from Normal Mobility to Minimal Mobility Impairment People with multiple sclerosis experience reduced income and earning potential as their mobility impairment increases, according to data collected from more than ...

Comment?

Related Topix: Medicine, Multiple Sclerosis, Health, Hawthorne, NY, University of Colorado Health Sciences Center, Biotech, Acorda Therapeutics, Healthcare Industry, Medication

Also on Topix